Top compounds associated with response to TMEM178B


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.079 0.04
mRNA VX-680 CTRPv2 pan-cancer AAC 0.3 0.04
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.075 0.04
mRNA Bax channel blocker CTRPv2 pan-cancer AAC 0.086 0.04
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.071 0.04
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA MS-275 CTRPv2 pan-cancer AAC 0.073 0.04
mRNA prochlorperazine CTRPv2 pan-cancer AAC 0.082 0.04
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.04
mRNA CIL70 CTRPv2 pan-cancer AAC 0.1 0.04
Download CSV